List Title | APhA DrugInfoLine

Alternative Medicines Corner

SORT BY: Most Recent Most Viewed

June 10, 2019

Vitamin D supplementation did not improve outcomes in patients with cancer

READ

PREVIEW
Results of two studies published in JAMA, the SUNSHINE and AMATERASU trials, showed that vitamin D supplementation did not significantly improve progression-free survival in patients with...
May 28, 2019

Kratom overdoses are on the rise, with serious adverse outcomes

READ

PREVIEW
Exposure to kratom has skyrocketed in recent years, with overdoses resulting in adverse effects such as agitation/irritability, tachycardia, and even death, according to an analysis published in ...
February 26, 2019

Another negative trial for vitamin D supplementation

READ

PREVIEW
Supplementation with high-dose vitamin D in older adults did not lower the incidence of invasive cancer or adverse cardiovascular (CV) events compared with placebo, according to results of the...
February 19, 2019

Glucosamine may be an option for knee osteoarthritis

READ

PREVIEW
Decreases in pain for patients with knee osteoarthritis were observed for celecoxib and glucosamine sulfate, but the effect only remained significant for glucosamine sulfate once the data were...
October 9, 2018

Glutamine may be an option for postinfectious irritable bowel syndrome

READ

PREVIEW
Use of glutamine supplementation in patients with postinfectious diarrhea-predominant irritable bowel syndrome (IBS-D) resulted in greater improvements in gastrointestinal (GI) symptoms and...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.